A 6-month-old infant with ventricular septal defect (VSD) is seen in the clinic for follow-up and exhibits poor weight gain and tachypnea. Which nursing intervention should be the highest priority?

Administering prescribed furosemide reduces pulmonary congestion by promoting diuresis, which directly addresses the tachypnea and poor weight gain associated with heart failure in VSD. This is the highest priority nursing intervention to stabilize the infant's condition.

Understanding the Priority: Why Furosemide Comes First

The infant's clinical picture of poor weight gain and tachypnea in the setting of a ventricular septal defect (VSD) points directly to heart failure (HF). A VSD creates a left-to-right shunt, forcing blood from the high-pressure left ventricle into the right ventricle and pulmonary artery. This leads to pulmonary overcirculation and congestion. The work of breathing increases (tachypnea), and the metabolic demand of labored breathing, combined with the body's attempt to compensate for reduced cardiac efficiency, burns calories at a rate that easily outpaces intake, causing poor weight gain.

The highest priority intervention is to address the root physiological problem: the excessive pulmonary blood flow that is driving the symptoms. Administering the prescribed furosemide directly reduces intravascular volume and decreases venous return to the right heart. This action lowers the preload, which in turn reduces the volume of blood shunted into the pulmonary circuit. By decongesting the lungs, the work of breathing decreases, and the infant's metabolic demand can stabilize, creating a physiological environment where nutritional interventions can actually succeed.

Analyzing the Other Options

- Option 1: Encourage increased fluid intake. This is contraindicated. In a state of pulmonary congestion from a left-to-right shunt, increasing total body fluid volume would worsen the congestion, increase the work of breathing, and further tax the failing heart. Fluid management in VSD-related heart failure is often restrictive, not liberal.
- Option 3: Provide high-calorie formula every 2 hours to promote weight gain. While optimizing nutrition is a critical long-term goal for these infants, it is not the immediate priority. Feeding is a significant stressor for a tachypneic infant in heart failure; they tire easily and risk aspiration. Attempting to aggressively feed a child with uncorrected pulmonary congestion is ineffective and potentially dangerous. The respiratory status must be stabilized first to lower metabolic demand and make safe, effective feeding possible.
- Option 4: Administer oxygen therapy at 6 L/min via nasal cannula. This is a dangerous intervention for an infant with a VSD. The primary cause of the tachypnea is not a pulmonary diffusion defect but rather excessive blood flow. Administering supplemental oxygen acts as a pulmonary vasodilator. Decreasing pulmonary vascular resistance will actually increase the magnitude of the left-to-right shunt, worsening the pulmonary edema and heart failure symptoms. Oxygen therapy is used with extreme caution in this population and is not a first-line treatment for this clinical presentation.

The systematic review on optimizing hemostasis in neonatal and infant cardiac surgery underscores the profound physiological vulnerability of this population, particularly the challenges of managing hemodynamics and fluid shifts. While its focus is on the operative setting, the principle of meticulous hemodynamic management is directly transferable to the medical management of a VSD. The core issue is a volume overload state in the pulmonary circuit, and the priority is to manage that volume with diuresis, not to add more fluid or inadvertently increase the shunt with oxygen.